Keeping this in mind, we focused on the potential role of urinary EGF as a biomarker in ADPKD, and left a comparison of the predictive value of urinary EGF in ADPKD versus in other kidney diseases beyond the scope of the present study. This evidence concerns the gene EGF and autosomal dominant polycystic kidney disease.